Michael Sela
YOU?
Author Swipe
View article: Kegiatan Mahasiswa KKN di Desa Bipak Kali dalam Membangun Generasi Cerdas Melalui Literasi Membaca dengan Inisiatif Bersama Karang Taruna Kecamatan Gunung Bintang Awai Kabupaten Barito Selatan
Kegiatan Mahasiswa KKN di Desa Bipak Kali dalam Membangun Generasi Cerdas Melalui Literasi Membaca dengan Inisiatif Bersama Karang Taruna Kecamatan Gunung Bintang Awai Kabupaten Barito Selatan Open
This research aims to improve reading literacy among children in Bipak Kali Village through collaboration between KKN students and Karang Taruna. This program focuses on increasing reading interest, reading ability, and access to literacy …
View article: Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate Open
The severe motor impairment in the MS animal model experimental autoimmune encephalomyelitis (EAE) obstructs the assessment of cognitive functions. We developed an experimental system that evaluates memory faculties in EAE-affected mice, i…
View article: Can remyelination be enhanced by immunomodulatory therapeutic modality?
Can remyelination be enhanced by immunomodulatory therapeutic modality? Open
An essential challenge for multiple sclerosis (MS) therapy is not only to ameliorate the inflammatory aspect of the disease, but to promote repair and remyelination. Glatiramer acetate (GA, Copaxone), an approved MS treatment, has been sho…
View article: Ephraim Katchalski-Katzir. 16 May 1916 — 30 May 2009
Ephraim Katchalski-Katzir. 16 May 1916 — 30 May 2009 Open
Ephraim Katchalski-Katzir was a leading researcher in the development of polyamino acids, which allowed new insights into the reactions and behaviour of proteins. His work developed pathways into the exploration and investigation of antige…
View article: Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18 Open
Antibody‐based therapy of cancer employs monoclonal antibodies (mAbs) specific to soluble ligands, membrane antigens of T‐lymphocytes or proteins located at the surface of cancer cells. The latter mAbs are often combined with cytotoxic reg…